论文部分内容阅读
目的比较不同化疗方案在结直肠癌治疗中的疗效和安全性。方法选取广西北海市人民医院2014年3月—2016年3月收治的结直肠癌患者137例,根据治疗方法的不同分为观察组71例与对照组66例。观察组给予替吉奥+奥沙利铂化疗,对照组给予奥沙利铂+卡西他滨化疗。比较两组患者客观有效率(ORR)、疾病控制率(DCR)及毒副作用发生率。结果两组患者ORR、DCR比较,差异无统计学意义(P>0.05)。观察组毒副作用发生率低于对照组,差异有统计学意义(P<0.05)。结论对于结直肠癌患者,临床选择替吉奥+奥沙利铂实施化疗,可以获得明显的化疗效果,表现出的化疗安全性较好,可有效降低血小板计数减少发生率,从而改善患者临床症状,为结直肠癌疾病预后质量的提高做出有效保证,提高患者生存质量。
Objective To compare the efficacy and safety of different chemotherapy regimens in the treatment of colorectal cancer. Methods 137 patients with colorectal cancer who were admitted to Beihai People’s Hospital of Guangxi from March 2014 to March 2016 were divided into observation group (71 cases) and control group (66 cases) according to the different treatment methods. The observation group was treated with tioguanxide + oxaliplatin and the control group was given oxaliplatin plus capecitabine. The objective efficiency (ORR), disease control rate (DCR) and incidence of side effects were compared between the two groups. Results There was no significant difference in ORR and DCR between the two groups (P> 0.05). The incidence of side effects in the observation group was lower than that in the control group, the difference was statistically significant (P <0.05). Conclusion For patients with colorectal cancer, the clinical choice of chemotherapy for the treatment of tiger-plus oxaliplatin can obtain a significant effect of chemotherapy, which shows better chemotherapy safety and can effectively reduce the incidence of platelet count reduction and thus improve the clinical symptoms , To make an effective guarantee for improving the quality of prognosis of colorectal cancer and improve the quality of life of patients.